Novel ribozyme, RNA decoy, and siRNA approaches to inhibition of HIV in a gene therapy setting

Clinical and Applied Immunology Reviews

Volumn 3, Issue 4-5, 2003, Pages 223-233

  Michienzi, Alessandro ^a   Castanotto, Daniela ^a   Lee, Nancy ^a   Li, Shirley ^a   Zaia, John A ^a   Rossi, John J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Gene therapy; HIV 1; Nucleolar RNA decoys; Retroviral vector; Ribozymes; siRNAs

Indexed keywords

ANTIRETROVIRUS AGENT; CD34 ANTIGEN; DNA; DOUBLE STRANDED RNA; LENTIVIRUS VECTOR; MESSENGER RNA; PROTEIN REVM 10; PROTEINASE INHIBITOR; RETROVIRUS VECTOR; REV PROTEIN; RIBOZYME; RNA; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; GENE TECHNOLOGY; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MUTATION RATE; PATHOGENESIS; REVIEW; VIRUS DNA CELL DNA INTERACTION; VIRUS INHIBITION; VIRUS MUTATION; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 0141818039     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-1049(02)00155-1     Document Type: Review

References (34)

1. Bossi P. Martinez V. Strady C. Bricaire F. Current antiretroviral therapy Rev Med Interne 22 1 2001 42-52
2. Bridges S.H. Sarver N. Gene therapy and immune restoration for HIV disease Lancet 345 8947 1995 427-432
3. Rossi J.J. Cantin E.M. Sarver N. Chang P.F. The potential use of catalytic RNAs in therapy of HIV infection and other diseases Pharmacol Ther 50 2 1991 245-254
4. Zhou C. Bahner I.C. Larson G.P. Zaia J.A. Rossi J.J. Kohn D.B. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes Gene 149 1 1994 33-39
5. Bauer G. Valdez P. Kearns K. Bahner I. Wen S.F. Zaia J.A. Kohn D.B. Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes Blood 89 7 1997 2259-2267
6. Miyoshi H. Smith K.A. Mosier D.E. Verma I.M. Torbett B.E. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors Science 283 5402 1999 682-686
7. Kingsman S.M. Kingsman A.J. The regulation of human immunodeficiency virus type-1 gene expression Eur J Biochem 240 3 1996 491-507
8. Dundr M. Leno G.H. Lewis N. Rekosh D. Hammarskjold M.L. Olson M.O. Location of the HIV-1 Rev protein during mitosis: inactivation of the nuclear export signal alters the pathway for postmitotic reentry into nucleoli J Cell Sci 109 Pt 9 1996 2239-2251
9. Dundr M. Leno G.H. Hammarskjold M.L. Rekosh D. Helga Maria C. Olson M.O. The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein J Cell Sci 108 Pt 8 1995 2811-2823
10. Ruben S. Perkins A. Purcell R. Joung K. Sia R. Burghoff R. Haseltine W.A. Rosen C.A. Structural and functional characterization of human immunodeficiency virus tat protein J Virol 63 1 1989 1-8
11. Kubota S. Pomerantz R.J. The nuclear function of the nuclear diffusion inhibitory signal of human immunodeficiency virus type 1: critical roles in dominant nuclear localization and intracellular stability J Hum Virol 3 4 2000 173-181
12. Michienzi A. Lagnon L. Bahner I. Rossi J.J. Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA Proc Natl Acad Sci USA 97 16 2000 8955-8960
13. Fragapane P. Prislei S. Michienzi A. Caffarelli E. Bozzoni I. A novel small nucleolar RNA (U16) is encoded inside a ribosomal protein intron and originates by processing of the pre-mRNA EMBO J 12 7 1993 2921-2928
14. Weinstein L.B. Steitz J.A. Guided tours: from precursor snoRNA to functional snoRNP Curr Opin Cell Biol 11 3 1999 378-384
15. Buonomo S.B. Michienzi A. De Angelis F.G. Bozzoni I. The Rev protein is able to transport to the cytoplasm small nucleolar RNAs containing a Rev binding element RNA 5 8 1999 993-1002
16. Michienzi A. Li S. Zaia J.A. Rossi J.J. A nucleolar TAR decoy inhibitor of HIV Replication Proc Natl Acad Sci USA 99C22 2002 14047-14052
17. Foley G.E. Lazarus H. Farber S. Geren Uzman B. Boone B.A. McCarthy R.E. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia Cancer 18 1965 522-529
18. Moss E.G. RNA interference: it's a small RNA world Curr Biol 11 19 2001 R772-R775
19. Bernstein E. Denli A.M. Hannon G.J. The rest is silence RNA 7 11 2001 1509-1521
20. Elbashir S.M. Lendeckel W. Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs Genes Dev 15 2 2001 188-200
21. Elbashir S.M. Harborth J. Lendeckel W. Yalcin A. Weber K. Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 6836 2001 494-498
22. Bernstein E. Caudy A.A. Hammond S.M. Hannon G.S. Role for a bidentate ribonuclease in the initiation step of RNA interference Nature 409 6818 2001 363-366
23. Hammond S.M. Boettcher S. Caudy A.A. Kobayashi R. Hannon G.J. Argonaute2, a link between genetic and biochemical analyses of RNAi Science 293 5532 2001 1146-1150
24. Lee N.S. Dohjima T. Bauer G. Li H. Li M.J. Ehsani A. Saluaterra P. Rossi J.J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells Nat Biotechnol 20 5 2002 500-505
25. Miyagishi M. Taira K. U6 promoter driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells Nat Biotechnol 20 5 2002 497-500
26. Paul C.P. Good P. Winer I. Engelke D.R. Effective expression of small interfering RNA in human cells Nat Biotechnol 20 5 2002 505-508
27. Brummelkamp T.R. Bernards R. Agami R. A system for stable expression of short interfering RNAs in mammalian cells Science 296 5567 2002 550-553
28. Yang S. Delgado R. King S. Woffedin C. Baker C.S. Yang Z.Y. Yu L. Nolan G.P. Nabel G.J. Generation of retroviral vector for clinical studies using transient transfection Hum Gene Ther 10 1 1999 123-132
29. Bahner I. Zhou C. Yu X.J. Hao Q.L. Guatelli J.C. Kohn D.B. Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes J Virol 67 6 1993 3199-3207
30. Ragheb J.A. Bressler P. Daucher M. Chang L. Chuah M.K. Vandendriessche T. Morgan R.A. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics AIDS Res Hum Retroviruses 11 11 1995 1343-1353
31. Chinen J. Aguilar-Cordoua E. Ng-Tang D. Lewis D.E. Belmont J.W. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene Hum Gene Ther 8 7 1997 861-868
32. Poznansky M.C. Foxal R. Mhashilkar A. Coker R. Jones S. Ramsted U. Marasco W. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat Hum Gene Ther 9 4 1998 487-496
33. Chen S.Y. Bagley J. Marasco W.A. Intracellular antibodies as a new class of therapeutic molecules for gene therapy Hum Gene Ther 5 5 1994 595-601
34. Novina C.D. Murray M.F. Dykxkhoom D.M. Beresford P.J. Riess J. Lee S.K. Collman R.G. Lieberman J. Shankar P. Sharp P.A. siRNA-directed inhibition of HIV-1 infection Nat Med 8 7 2002 681-686